Article
A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jun 2011
Iversen Edwin S, Couch Fergus J, Goldgar David E, Tavtigian Sean V, Monteiro Alvaro N A
Abstract excerpt
BACKGROUND: Besides revealing cancer predisposition variants or the absence of any changes, genetic testing for cancer predisposition genes can also identify variants of uncertain clinical significance (VUS). Classifying VUSs is a pressing problem, as ever more patients seek genetic testing for disease syndromes and receive noninformative results from those tests. In cases such as the breast and ovarian cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
